These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7249253)

  • 41. Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.
    Antonini I; Polucci P; Cola D; Palmieri G; Martelli S; Bontemps-Gracz M
    Farmaco; 1993 Dec; 48(12):1641-8. PubMed ID: 8135988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
    Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxicity and antileukaemic activity of new duplexes linking 3-C-ethynylcytidine and 5-fluorodeoxyuridine.
    Novotny L; Rauko P; Schott H
    Anticancer Res; 2010 Dec; 30(12):4891-8. PubMed ID: 21187467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined therapy of mice bearing L1210 leukemia with adriamycin and mycobacteria.
    Fiszer L; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):873-9. PubMed ID: 749836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention by testosterone of the intestinal toxicity caused by the antitumor agent 3-deazauridine.
    Bloch A; Dutschman G; Grindey G; Simpson CL
    Cancer Res; 1974 Jun; 34(6):1299-303. PubMed ID: 4826501
    [No Abstract]   [Full Text] [Related]  

  • 46. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
    Zheng LM; Li Z; Liu L; Song BL; King I
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):45-51. PubMed ID: 17256135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined effect of lipoic acid and doxorubicin in murine leukemia.
    Dovinová I; Novotný L; Rauko P; Kvasnicka P
    Neoplasma; 1999; 46(4):237-41. PubMed ID: 10613604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of radiation, dihydroxyanthraquinone, and adriamycin on the induction of acute lethality in mice.
    Kimler BF; Cox GG; Reddy EK
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1459-63. PubMed ID: 6381433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
    Fiszer-Maliszewska L; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):703-10. PubMed ID: 7349092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dioxopiperazine derivative potentiates antitumor effect of methylglyoxal bis(cyclopentylamidinohydrazone) on human and mouse leukemia cells.
    Hibasami H; Tsukada T; Shirakawa S; Narita T; Inagaki M; Nakashima K
    Anticancer Res; 1994; 14(2A):561-4. PubMed ID: 8017861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell kinetic studies of the effect of a combined therapy with 1-beta D-arabinofuranosylcytosine (Ara-C) and X-irradiation on the L1210 ascites tumour.
    Fietkau R; Maurer-Schultze B
    Cell Tissue Kinet; 1986 Jan; 19(1):93-107. PubMed ID: 3513957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Curability of mouse L1210 leukemia by combination of 5-fluorouracil, cis-diamminedichloroplatinum(II), and low doses of gamma-rays.
    Dionet C; Verrelle P
    Cancer Res; 1984 Feb; 44(2):652-6. PubMed ID: 6537898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T; Szmigielska A
    Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):45-52. PubMed ID: 6860085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia.
    Nicolin A; Canti G; Goldin A
    Cancer Res; 1974 Nov; 34(11):3044-8. PubMed ID: 4424774
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of 5-aza-2'-deoxycytidine in combination with the biochemical modulator thymidine or the immune modulator pyran copolymer on L1210 leukemia-bearing mice.
    Zaharko DS; Covey JM
    Cancer Treat Rep; 1984 Oct; 68(10):1255-64. PubMed ID: 6084549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.